Validation of the Polish Version of BPS (POL-BPS).
POL-BPS
1 other identifier
observational
59
1 country
1
Brief Summary
Between 40 to 70% of patients with critical illness experience moderate to severe pain. Diagnosing pain and assessing its severity is difficult in non-verbal patients both in an Intensive Care Unit and in Postoperative Unit after a major surgery such as cardiac surgery). In patients who are unable to self-report pain, we use behavioural pain scales, namely BPS - Behavioural Pain Scale. Aim: The aim of this study was to validate the Polish version of a behavioural pain assessment method - BPS in intubated, sedated patients after cardiac surgery versus self assessment of pain using Numeric rating scale (NRS) in both delirious and non-delirious patients (assessed using Confusion Assessment Method for ICU, CAM-ICU). Method: A prospective observational cohort study will include 60 patients. The patients will be observed by two trained observers during a nociceptive procedure (position change), both during analgosedation and analgesia. Patients will be observed 5 minutes before, during, and 15 min after the two sets of interventions (six assessments in total). Each BPS assessment will be carried out by two observers blinded to each other. To validate the Polish BPS translation we will use the following methods: calculations of interrater reliability, criterion validity and discriminant validity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 20, 2017
CompletedFirst Posted
Study publicly available on registry
April 25, 2017
CompletedStudy Start
First participant enrolled
June 12, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2017
CompletedSeptember 20, 2017
September 1, 2017
3 months
April 20, 2017
September 18, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Interrater variability for Polish BPS.
Validation of Polish BPS.
Through study completion and up to 24 weeks.
Secondary Outcomes (2)
Criterion validity for Polish BPS.
Through study completion and up to 24 weeks.
Discriminant validity for Polish BPS
Through study completion and up to 24 weeks.
Study Arms (2)
CAM-ICU (+) Delirious patients.
Behavioral: BPS assessment Polish version of BPS tool validation. Other Names: Pain assessment in non-verbal patients
CAM-ICU (-) Non-delirious patients.
Behavioral: BPS assessment Polish version of BPS tool validation. Other Names: Pain assessment in non-verbal patients
Interventions
Validation of Polish Version of BPS.
Eligibility Criteria
Intubated adult ICU patients at the Postoperative Cardiac Surgery Unit of the tertiary teaching hospital at the Pomeranian Medical University in Szczecin, Poland undergoing minimal analgesia-based sedation protocol (dexmedetomidine + morphine intravenous infusion).
You may qualify if:
- Age above 18 years
- Ability to communicate in the Polish language,
- Intubated and mechanically ventilated patients (controlled modes, spontaneous modes),
- Richmond Agitation Sedation Scale (RASS) above or equal to -3,
- Unrestricted sight and hearing,
- No limitations for body position changing,
- After Cardiac surgery
You may not qualify if:
- A medical need for deep sedation - treatment of severe respiratory failure associated with patient-ventilator dyssynchrony, preventing awareness during neuromuscular blockade, status epilepticus, certain surgical conditions requiring immobility , cases of severe brain injury with intracranial hypertension
- Facial trauma (unable to evaluate facial expression),
- Richmond Agitation Sedation Scale (RASS) -4 or -5
- Neurological or psychiatric disorders,
- Use of neuromuscular blocking agents,
- Regular narcotic users,
- Chronic pain syndrome patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pomeranian Medical University
Szczecin, 70-111, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Katarzyna L Kotfis, MD,PhD
Pomeranian Medical University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Katarzyna Kotfis M.D. Ph.D.
Study Record Dates
First Submitted
April 20, 2017
First Posted
April 25, 2017
Study Start
June 12, 2017
Primary Completion
August 30, 2017
Study Completion
August 30, 2017
Last Updated
September 20, 2017
Record last verified: 2017-09